Untreated sleep apnea is associated with a significantly higher risk of dying from any cause, and severe cases carry the greatest danger. One community-based study found that people with moderate-to-severe obstructive sleep apnea (OSA) had roughly six times the mortality risk of those without the condition, even after accounting for other health factors.1PubMed Central. Sleep Apnea as an Independent Risk Factor for All-Cause Mortality: The Busselton Health Study The threat goes well beyond feeling tired during the day. Untreated sleep apnea quietly damages the cardiovascular system, disrupts metabolism, raises the odds of stroke and dementia, and even alters cancer risk, making it one of the more consequential conditions a person can leave unaddressed.
How Sleep Apnea Raises Mortality Risk
Sleep apnea causes the airway to repeatedly narrow or collapse during sleep, cutting off airflow for seconds to over a minute at a time. Each episode triggers a drop in blood oxygen and a brief arousal that the sleeper rarely remembers. In severe cases, this cycle can repeat dozens of times per hour, all night long. The cumulative damage is what makes the condition dangerous over years.
Large cohort studies consistently show that the more severe the apnea, the higher the risk of death. In one long-term analysis adjusting for age, sex, body weight, blood pressure, diabetes, smoking, and cholesterol, severe OSA was linked to about a 38 percent increase in all-cause mortality.2PubMed Central. Long-term All-Cause Mortality Risk in Obstructive Sleep Apnea Using Hypopneas Defined by a ≥3 Percent Oxygen Desaturation or Arousal In the Busselton Health Study, the fully adjusted hazard ratio for moderate-to-severe OSA was 6.24, meaning participants in that group were more than six times as likely to die during follow-up compared to those without sleep apnea.1PubMed Central. Sleep Apnea as an Independent Risk Factor for All-Cause Mortality: The Busselton Health Study Mild cases, by contrast, did not show the same independent mortality risk, which suggests severity is the critical variable.
Cardiovascular Damage
The heart and blood vessels take the hardest hit. Every time breathing stops, the body’s sympathetic nervous system fires up as if responding to an emergency. Blood pressure spikes, stress hormones flood the bloodstream, and the lining of blood vessels sustains damage from oxidative stress and inflammation.3PubMed Central. Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components Over months and years, this promotes atherosclerosis, stiffens arteries, and pushes blood pressure higher even during the day.
Multiple mechanisms pile on at once: the sympathetic nervous system stays chronically overactive, inflammatory molecules circulate at elevated levels, blood becomes more prone to clotting, and the body’s ability to regulate insulin and lipids degrades.4PubMed. Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk Research on cells exposed to the kind of on-off oxygen cycling that sleep apnea produces has shown that it selectively ramps up inflammatory pathways while suppressing the body’s normal adaptive response to low oxygen. In people with OSA, levels of tumor necrosis factor-alpha, a key inflammatory marker, were roughly double those of healthy controls, and these levels dropped back to normal once treatment with positive airway pressure was started.5PubMed. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome
Sudden Cardiac Death During Sleep
For most people, the lowest-risk hours for sudden cardiac death are between midnight and 6 a.m. In people with OSA, the pattern flips. A study examining sudden cardiac deaths found that 46 percent of those in people with OSA occurred during those overnight hours, compared to 21 percent in people without sleep apnea and 16 percent in the general population. The relative risk of dying suddenly from a cardiac event during those hours was about 2.6 times higher for people with OSA, and the more severe the apnea, the greater that risk.6PubMed. Day-night pattern of sudden death in obstructive sleep apnea This reversal of the normal circadian pattern is one of the starkest illustrations of how sleep apnea turns the hours meant for rest and recovery into hours of physiological stress.
Stroke
Sleep apnea roughly doubles the risk of stroke. A study published in the New England Journal of Medicine followed patients over several years and found that after adjusting for age, sex, smoking, body weight, diabetes, high cholesterol, atrial fibrillation, and hypertension, OSA retained a statistically significant association with stroke or death, with an adjusted hazard ratio of about 1.97.7PubMed. Obstructive sleep apnea as a risk factor for stroke and death In older adults specifically, severe sleep apnea was associated with roughly 2.5 times the risk of ischemic stroke over a six-year period.8PubMed. Severe sleep apnea and risk of ischemic stroke in the elderly
What makes these findings especially concerning is that sleep apnea often coexists with other stroke risk factors like high blood pressure and atrial fibrillation. The adjusted analyses in these studies tried to separate the independent contribution of sleep apnea itself, and the link held. Clinicians are increasingly encouraged to screen stroke and transient ischemic attack patients for sleep apnea, since treating it may help prevent recurrence while also addressing conditions like diabetes and hypertension that tend to travel alongside it.9PubMed Central. Obstructive sleep apnea and stroke
Metabolic Consequences
The intermittent drops in oxygen that define sleep apnea do not just stress the heart. They also interfere with how the body processes sugar. Animal studies and human data show that the repeated hypoxia-reoxygenation cycles impair insulin sensitivity, essentially making cells less responsive to insulin’s signal to absorb glucose.10European Respiratory Journal. Sleep apnoea, insulin resistance and diabetes: the first step is in the fat The mechanism appears to involve fat tissue directly: intermittent hypoxia disrupts how fat cells respond to insulin at the molecular level, downgrading their ability to take up glucose.
Population-level data reinforce the link. OSA is independently associated with both the development and poorer control of type 2 diabetes, through a combination of sleep fragmentation, sympathetic nervous system activation, and chronic inflammation.11PubMed Central. Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea For someone already at risk of diabetes due to weight, genetics, or lifestyle, untreated sleep apnea adds a second metabolic insult that can accelerate disease progression.
Dementia and Cognitive Decline
Sleep is when the brain consolidates memory and clears metabolic waste. When that process is disrupted hundreds of times a night, the long-term cognitive consequences are real. A systematic review and meta-analysis found that patients with sleep apnea had about a 43 percent increased risk of developing any type of neurocognitive disorder, a 28 percent increased risk of Alzheimer’s disease, and a 54 percent increased risk of Parkinson’s disease.12PubMed. Sleep apnea and the risk of dementia: A systematic review and meta-analysis The association held for Alzheimer’s and Parkinson’s disease but, interestingly, not for vascular dementia specifically. The reasons for that distinction are still being worked out, but the direction of the evidence makes untreated sleep apnea a meaningful risk factor for cognitive decline in older adults.
Depression and Quality of Life
Untreated sleep apnea takes a toll on mental health that goes beyond fatigue. A meta-analysis pooling data from multiple studies found that roughly 23 percent of people with OSA met criteria for clinical depression.13Sleep Medicine. Clinical depression in untreated obstructive sleep apnea: examining predictors and a meta-analysis of prevalence rates Depression among people with OSA was most strongly linked to impaired quality of life rather than to the severity of sleep apnea itself, suggesting the daily burden of poor sleep, fatigue, and reduced function drives much of the psychological distress.
When researchers used structured psychiatric interviews, they found that about 15.5 percent of untreated OSA patients met criteria for dysthymia (a persistent, lower-grade depressive state), and about 6 percent qualified for major depression. Women were diagnosed with dysthymia at nearly three times the rate of men.14PubMed Central. The Prevalence of Depression among Untreated Obstructive Sleep Apnea Patients Using a Standardized Psychiatric Interview The mental health angle matters because depression in someone with undiagnosed sleep apnea can be treated with antidepressants for years without addressing the underlying cause.
Driving Risk
Excessive daytime sleepiness makes untreated sleep apnea a hazard behind the wheel. A systematic review and meta-analysis found that people with OSA are clearly at increased risk for motor vehicle crashes, with the average crash-rate ratio falling somewhere between 1.2 and 4.9 times higher than normal.15PubMed Central. Obstructive sleep apnea and risk of motor vehicle crash: systematic review and meta-analysis A large population-based study of nearly 880,000 people pegged the increased risk at about 17 percent after adjusting for other factors, a more modest figure that reflects the full spectrum of severity including mild cases.16PubMed. Obstructive sleep apnea and risk of motor vehicle accident
Treatment appears to help. In one comparative analysis, OSA patients who had undergone sleep surgery had a motor vehicle accident rate of about 3.4 percent, compared to 4.7 percent in untreated patients and 6.1 percent in those using CPAP (though the CPAP group may reflect different baseline severity or adherence challenges).17PubMed Central. Risk of Motor Vehicle Accidents in Obstructive Sleep Apnea: Comparative Analysis of CPAP Versus Surgery The main takeaway: the sleepiness produced by untreated sleep apnea is not just an annoyance. It is a safety risk with documented consequences.
Central Sleep Apnea Carries Its Own Risks
Most discussions of sleep apnea focus on the obstructive type, where the airway physically collapses. Central sleep apnea (CSA) is a different condition in which the brain intermittently fails to send the signal to breathe. CSA often accompanies heart failure, stroke, or opioid use, and its prognosis is generally worse. In a large retrospective study of veterans, 25 percent of patients with CSA died during the study period, compared to about 15 percent of those with OSA. The median time to death after diagnosis was 2.7 years for CSA versus 5.1 years for OSA, and after adjusting for sex, race, body weight, age, and other health conditions, CSA was still associated with significantly higher mortality.18PubMed Central. Mortality Patterns Associated with Central Sleep Apnea among Veterans: A Large, Retrospective, Longitudinal Report The higher mortality in CSA is partly because it tends to appear alongside serious underlying conditions, but it remains an independent risk factor even after accounting for those.
Why Women Are Underdiagnosed
Sleep apnea has traditionally been seen as a condition affecting overweight middle-aged men, and that stereotype has left many women undiagnosed. Women with OSA tend to present differently: they more often describe insomnia as their primary complaint rather than the classic loud snoring and witnessed breathing pauses that prompt referrals in men. Women with OSA at the time of diagnosis are also several times more likely to already be treated for depression and to have hypothyroid disease.19Sleep. Differences between Men and Women in the Clinical Presentation of Patients Diagnosed with Obstructive Sleep Apnea Syndrome This means a woman with sleep apnea may cycle through multiple prescriptions for insomnia and depression before anyone investigates her breathing during sleep.
The underdiagnosis is not limited to clinical presentation differences. Sleep research itself has historically been conducted primarily on male patients, leading to underestimates of prevalence and severity in women.20PubMed. Obstructive sleep apnea syndrome (OSAS) in women: A forgotten cardiovascular risk factor For women, the cardiovascular consequences of untreated OSA are just as significant, yet the condition remains underrecognized.21PubMed Central. Gender Issues in Obstructive Sleep Apnea
Children Are Not Immune
Sleep apnea in children, most often caused by enlarged tonsils and adenoids, poses its own set of dangers. Untreated pediatric OSA can lead to cognitive deficits, attention and behavioral problems that mimic ADHD, emotional instability, and poor academic achievement. In younger children, it can cause failure to thrive and developmental delays. Mild pulmonary hypertension is not uncommon, and in rare untreated cases, cardiovascular complications like heart failure can develop.22PubMed Central. Obstructive sleep apnea syndrome in children: Epidemiology, pathophysiology, diagnosis and sequelae
The consequences do not necessarily end when a child grows up. A twenty-year follow-up study found that young adults who had severe OSA in childhood had significantly higher body weight, more snoring, and fewer academic degrees compared to controls. Childhood apnea severity also trended toward predicting cardiovascular outcomes in adulthood.23PubMed Central. Twenty-year follow-up of children with obstructive sleep apnea The physiological effects of pediatric OSA, if left unaddressed, can shift from reversible to pathological.24PubMed Central. You Cannot Hit Snooze on OSA: Sequelae of Pediatric Obstructive Sleep Apnea
The Link Between Sleep Apnea and Cancer
This is a newer and still-evolving area of research, but the signal is hard to ignore. A systematic review and meta-analysis found that OSA patients with moderate nocturnal hypoxemia (spending more than about 1 percent of sleep time with oxygen saturation below 90 percent) had roughly 28 percent higher cancer incidence, and those with severe hypoxemia had 43 percent higher cancer incidence compared to patients who maintained normal oxygen levels during sleep. The mortality finding was even more striking: severe nocturnal hypoxemia nearly tripled cancer-related deaths.25PubMed Central. Association of obstructive sleep apnea and nocturnal hypoxemia with all-cancer incidence and mortality: a systematic review and meta-analysis
It appears that the oxygen desaturation component of sleep apnea, rather than the total number of breathing interruptions, is the stronger predictor of cancer outcomes. In one large multicenter study, the percentage of sleep time spent at low oxygen and the amount of light, fragmented sleep were significantly associated with cancer-specific mortality, while the overall apnea severity index by itself was not.26Annals of the American Thoracic Society. Polysomnographic Markers of Obstructive Sleep Apnea Severity and Cancer-related Mortality: A Large Retrospective Multicenter Clinical Cohort Study Specific cancer types have also been investigated; for instance, lung cancer showed a statistically significant association with both the apnea-hypopnea index and nocturnal oxygen drops.27PubMed. Obstructive sleep apnea and nocturnal hypoxemia are associated with an increased risk of lung cancer Researchers are still working out the exact biological pathways, but the intermittent hypoxia and chronic inflammation that define untreated sleep apnea are both known to promote the kinds of cellular changes that can drive tumor growth.
Does Treatment Reverse the Risk?
The most direct evidence comes from studies on positive airway pressure (PAP) therapy, the standard treatment that uses a mask to keep the airway open during sleep. A systematic review and meta-analysis found that PAP therapy was associated with a 37 percent reduction in all-cause mortality and a 55 percent reduction in cardiovascular mortality compared to no treatment. The benefit increased with greater use of the device.28The Lancet Respiratory Medicine. Association of positive airway pressure therapy with mortality in obstructive sleep apnoea: a systematic review and meta-analysis Adherence matters: one long-term study found that using CPAP for more than four hours per night was associated with a significant reduction in all-cause mortality over roughly nine years of follow-up.29PubMed. Long-term outcomes of CPAP-treated sleep apnea patients: Impact of blood-pressure responses after CPAP initiation and of treatment adherence
Not everyone tolerates CPAP, and a growing body of evidence supports alternatives. A systematic review and network meta-analysis comparing non-drug treatments found that mandibular advancement devices (oral appliances that hold the lower jaw forward) were the most effective alternative for improving depression, and they also improved apnea severity and quality of life, though not as much as PAP for moderate-to-severe cases. Surgical approaches, oropharyngeal exercises, acupuncture, and neurostimulation showed varying degrees of promise, but the evidence for most remains thin.30PubMed. Comparative efficacy of non-pharmacological interventions for adults with sleep apnea: A systematic review and network meta-analysis The key point is that some form of treatment, even an imperfect one, is substantially better than no treatment at all.
Surgical and Anesthetic Risks for Undiagnosed Cases
A less obvious danger of untreated sleep apnea is what happens when someone with the condition goes under anesthesia for surgery without anyone knowing about their apnea. Sedatives and anesthetic agents relax the upper airway muscles, making the airway even more collapsible than usual. This increases the risk of postoperative complications like oxygen desaturation, difficult intubation, and respiratory emergencies in the recovery room. The majority of people with sleep apnea are undiagnosed, which means they go into surgical procedures without the precautions that a known diagnosis would trigger.31PubMed Central. Obstructive sleep apnea syndrome and perioperative complications: a systematic review of the literature Pre-surgical screening questionnaires for sleep apnea have become more common for exactly this reason.
The Economic Scale of the Problem
Untreated sleep apnea does not just cost lives. An estimated 936 million adults worldwide have some form of the condition, and those who remain untreated generate healthcare costs roughly 2.5 times higher than people without OSA. The annual societal cost of untreated sleep apnea in the United States alone exceeds an estimated $150 billion when factoring in direct medical expenses, lost productivity, and accident-related costs.32PubMed Central. The Global Socioeconomic Burden of Obstructive Sleep Apnea: A Comprehensive Review Per-patient annual costs range widely by country, from a few hundred euros in New Zealand (reflecting just the incremental cost of having OSA) to over €28,000 in the United States.33PubMed. The economic cost of obstructive sleep apnea: A systematic review OSA-related healthcare costs begin rising years before the diagnosis is made and remain elevated for a long time after, reflecting the accumulated damage of years spent untreated.34PubMed Central. Clinical consequences and economic costs of untreated obstructive sleep apnea syndrome